Emergent Biosolutions Inc. Stock
A loss of -2.880% shows a downward development for Emergent Biosolutions Inc..
Based on 2 Buy predictions and 3 Sell predictions the sentiment towards Emergent Biosolutions Inc. is rather balanced.
On the other hand, the target price of 4 € is above the current price of 1.8 € for Emergent Biosolutions Inc., so the potential is actually 122.28%.
Our community identified positive and negative aspects for Emergent Biosolutions Inc. stock for the coming years. 1 users see the criterium "Company culture" as a plus for the Emergent Biosolutions Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Emergent Biosolutions Inc. in the next few years
Pros
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Emergent Biosolutions Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc. | -2.880% | -5.785% | -23.426% | -77.562% | -19.232% | -96.481% | -96.254% |
| Novocure Ltd | 1.610% | 4.053% | -18.355% | -80.257% | -17.268% | -93.030% | - |
| Sage Therapeutics Inc. | 2.860% | 2.037% | -26.580% | -70.428% | -36.125% | -80.292% | - |
| Iovance Biotherapeutics Inc. | 3.220% | 2.211% | -20.519% | 112.456% | 39.152% | -58.641% | - |
Comments
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co..
Show more
Ratings data for EBS provided by MarketBeat